Adalimumab is the name of the active ingredient in HUMIRA. Your doctor, health insurance provider, or specialty pharmacist may refer to adalimumab when discussing HUMIRA biosimilar treatment options.

A process that confirms your benefits and eligibility or your insurance coverage for a prescription or medical service.

Biological medications (also called biological products) can be made of sugars, proteins, living cells, tissues, or a combination of these. They are made from natural and living sources like animal and plant cells, and microorganisms such as bacteria or yeast.

Biological medications are usually more complex than other drugs. They are often more complicated to purify, process, and manufacture.

A biosimilar is a biologic that is highly similar to, and has no clinically meaningful differences from, another biologic that’s already FDA-approved (called the reference product or original biologic).

A fixed amount you pay for a doctor’s visit, prescription, or other medical service.

A statement from your insurance administrator that details what charges are eligible for benefits under your plan.

The list of medicines that your health insurance plan will cover.

An interchangeable biosimilar product is a biosimilar that may be substituted for the reference product without the intervention of the health care professional who prescribed the reference product.

This is similar to how generic drugs are substituted for brand-name drugs at the pharmacy and is subject to state laws.

Interchangeable biosimilars must meet additional requirements related to the potential for automatic substitution.

Interchangeable biosimilars are approved by the FDA using the same high standards of approval as the original biologic.

The most you’ll pay in medical expenses in a year before you’re fully covered.

Your health care provider must provide additional information to your insurance company before they’ll cover a service or medication.